Why the study?
Do outcomes of carotid endarterectomy in the real-world Medicare population differ from those demonstrated in randomized controlled trials?
Do outcomes of carotid endarterectomy in the real-world Medicare population differ from those demonstrated in randomized controlled trials?
Real-world outcomes of carotid endarterectomy in Medicare patients are worse than those in randomized trials, particularly for patients with higher comorbidities or treated at hospitals with higher perioperative mortality.
Trial results for carotid endarterectomy may not generalize to Medicare patients; leaves open questions on applicability to higher-comorbidity groups.
OBJECTIVE: To compare the characteristics and outcomes demonstrated for participants in randomized controlled trials of carotid endarterectomy with those of the Medicare patient population who received the procedure in 1989. DESIGN: Historical cohort study using Medicare claims data. SETTING: Medicare beneficiary population aged 65 years and older. PATIENTS: Medicare patients 65 years and older who received carotid endarterectomy during 1989. MAIN OUTCOME MEASURES: Perioperative mortality rate and occurrence of transient ischemic attack, stroke, and death within 2 years of surgery. RESULTS: The risk for death within 2 years of the procedure was substantially higher among Medicare patients who received surgery in hospitals with perioperative mortality rates greater than rates demonstrated in the trials (odds ratio, 1.36; 95% confidence interval, 1.29-1.44) and among those with comorbidity that exceeded trial participation criteria (odds ratio, 1.72; 95% confidence interval, 1.64-1.84). CONCLUSIONS: Although carotid endarterectomy trials demonstrate the efficacy of the procedure, this evidence only applies to patients and hospitals with characteristics comparable to those of the trial participants. The importance of this consideration is demonstrated by the substantially higher odds of death experienced among Medicare patients receiving the procedure who had a level of comorbidity that exceeded that of the trial participants or who received their surgery in a hospital with a perioperative mortality rate that exceeded the experience of the hospitals in the trials.
No takes yet. Share an insight, caveat, or question.
George J. Stukenborg (1997) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: